当前位置： SCI文献检索 > INTERNATIONAL JOURNAL OF CANCER期刊下所有文献 > Late and very late mortality in 5-year survivors of childhood cancer: changing pattern over four decades--experience from the Nordic countries.

Late and very late mortality in 5-year survivors of childhood cancer: changing pattern over four decades--experience from the Nordic countries.

Abstract：

:Long-term survivors of childhood cancer suffer from a higher mortality than the general population. Here we evaluate late and very late mortality, and patterns of causes of death, in 5-year survivors after childhood and adolescent cancer in cases diagnosed during four decades in the five Nordic countries. The study is population-based and uses data of the nationwide cancer registries and the cause of death registers. There were in all 37,515 incident cases, diagnosed with cancer before the age of 20 years, between 1960 and 1999. The 5-year survivor cohort used in the mortality analyses consisted of 21,984 patients who were followed up for vital status until December 31, 2005 (Norway, Sweden) or 2006 (Denmark, Finland, Iceland). At the latest follow-up, 2,324 patients were dead. The overall standardized mortality ratio was 8.3 and the absolute excess risk was 6.2 per 1,000 person-years. The pattern of causes of death varied markedly between different groups of primary cancer diagnosis, and was highly dependent on time passed since diagnosis. With shorter follow-up the mortality was mainly due to primary cancer, while with longer follow-up, mortality due to second cancer and noncancer causes became more prominent. Mortality between 5 and 10 years after diagnosis continued to decrease in patients treated during the most recent period of time, 1990-1999, compared to previous periods, while mortality after 10 years changed very little with time period. We conclude that improvement of definite survival demands not only reducing early but also late and very late mortality.

journal_name

Int J Cancer

journal_title

International journal of cancer

authors

Garwicz S,Anderson H,Olsen JH,Winther JF,Sankila R,Langmark F,Tryggvadóttir L,Möller TR,Association of the Nordic Cancer Registries.,Nordic Society for Pediatric Hematology Oncology.

doi

10.1002/ijc.27393

subject

Has Abstract

pub_date

2012-10-01 00:00:00

pages

1659-66

issue

7

eissn

0020-7136

issn

1097-0215

journal_volume

131

pub_type

杂志文章

相关文献

INTERNATIONAL JOURNAL OF CANCER文献大全
  • Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype.

    abstract：:Farnesyl transferase inhibitors (FTIs) were shown to be effective in modulating tumor growth in Ras-transformed tumor cells. Recent studies have focused on Rho GTPases as putative targets of FTI action. Previously, we demonstrated that FTIs were effective in inhibiting the growth and invasiveness of RhoC GTPase-overex...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.25655

    authors： Chatterjee M,van Golen KL

    更新日期：2011-07-01 00:00:00

  • Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse.

    abstract：:The assessment of tumor molecular features in combination with the detection of occult malignant cells may provide important clinical information, beyond the standard staging of breast cancer. Using a nested RT-PCR technique, we assessed prospectively the presence of cytokeratin-19 (CK19) mRNA positive cells in the bl...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.11593

    authors： Giatromanolaki A,Koukourakis MI,Kakolyris S,Mavroudis D,Kouroussis C,Mavroudi C,Perraki M,Sivridis E,Georgoulias V

    更新日期：2004-02-10 00:00:00

  • Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.

    abstract：:Multiple myeloma (MM) is the second most common hematologic malignancy characterized by the clonal expansion of plasma cells. Despite continuing advances, novel biomarkers are needed for diagnosis and prognosis of MM. In our study, we characterized the diagnostic and prognostic potential of circulating microRNAs (miRN...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.29199

    authors： Hao M,Zang M,Wendlandt E,Xu Y,An G,Gong D,Li F,Qi F,Zhang Y,Yang Y,Zhan F,Qiu L

    更新日期：2015-04-15 00:00:00

  • Wnt2 as a new therapeutic target in malignant pleural mesothelioma.

    abstract：:Malignant mesothelioma of the pleura (MPM) is a highly aggressive neoplasm with a poor prognosis and limited treatment options. A better understanding of its pathogenesis is essential to developing alternative therapeutic strategies. We previously demonstrated that the Wnt signaling pathway is activated in MPM through...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.21160

    authors： Mazieres J,You L,He B,Xu Z,Twogood S,Lee AY,Reguart N,Batra S,Mikami I,Jablons DM

    更新日期：2005-11-01 00:00:00

  • Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines.

    abstract：:Recent studies suggest a potential role of lipid lowering drugs, fibrates and statins, in anticancer treatment. One candidate for tumor chemoprevention is fenofibrate, which is a potent agonist of peroxisome proliferator activated receptor alpha (PPARalpha). Our results demonstrate elevated expression of PPARalpha in ...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.23588

    authors： Urbanska K,Pannizzo P,Grabacka M,Croul S,Del Valle L,Khalili K,Reiss K

    更新日期：2008-09-01 00:00:00

  • NF-κ B-dependent upregulation of ICAM-1 by HPV16-E6/E7 facilitates NK cell/target cell interaction.

    abstract：:NK cell recognition of tumor cells is mediated by a delicate balance of signals received by MHC class I-binding inhibitory NK cell receptors and activating NK cell receptors, which mainly bind to virus-, stress- or tumor-induced ligands. In addition, adhesion molecules such as the intercellular adhesion molecule-1 (IC...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.25442

    authors： Textor S,Accardi R,Havlova T,Hussain I,Sylla BS,Gissmann L,Cerwenka A

    更新日期：2011-03-01 00:00:00

  • Iressa induces cytostasis and augments Fas-mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu.

    abstract：:Understanding the role of signal transduction in regulating pathways responsible for cell growth, survival and apoptosis is critical for cancer therapy. We developed and characterized a HER2/neu and Fas overexpressing cell line (BNT.888 ACA2) from a salivary gland adenocarcinoma that arose in a HER2/neu transgenic mou...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.21837

    authors： Piechocki MP,Yoo GH,Dibbley SK,Amjad EH,Lonardo F

    更新日期：2006-07-15 00:00:00

  • Antigens associated with chemically induced intestinal carcinomas of rats.

    abstract：:Rabbits were immunized with extracts of primary or grafted intestinal adeno-carcinomas induced by carcinogenic drugs in inbred rats. After absorption with normal tissue extracts, the antisera were able to recognize three tumor-associated antigens. Two of them were glycoproteins, present in cancer cells but also, in tr...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.2910150117

    authors： Martin F,Martin MS,Bordes M,Knobel S

    更新日期：1975-01-15 00:00:00

  • Obtaining smoking histories for population-based studies on multiple primary cancers: Connecticut, 2002.

    abstract：:Because of the absence of data on smoking history for patients in cancer registries, large population-based studies have been unable to directly assess the role of smoking in the risk of multiple primary cancers. In a random sample of 618 adults diagnosed with invasive cancer in 2002 and reported to the population-bas...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.21786

    authors： Polednak AP

    更新日期：2006-07-01 00:00:00

  • A case-control study of diet and gastric cancer in northern Italy.

    abstract：:Dietary factors in the aetiology of stomach cancer were investigated using data from a case-control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute, non-digestive conditions, unrelated to any of the potential risk factors for gastric cancer. D...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.2910400409

    authors： La Vecchia C,Negri E,Decarli A,D'Avanzo B,Franceschi S

    更新日期：1987-10-15 00:00:00

  • Propagation of a poorly differentiated human pulmonary adenocarcinoma in nude athymic rats.

    abstract：:Nude athymic rats of Rowett genetic background were injected subcutaneously with cells from a poorly differentiated human pulmonary adenocarcinoma, following propagation in nude mice. The tumour cells were obtained by thoracentesis and by pleural biopsy during thoracoscopy. So far, we have heterotransplanted 13 differ...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.2910320621

    authors： Korsgaard R,Lindén CJ,Willén R,Willén H,Svensson G,Simonsson BG

    更新日期：1983-12-15 00:00:00

  • Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancer.

    abstract：:Lysine-specific demethylase-1 (LSD1) removes the methyl groups from mono- and di-methylated lysine 4 of histone H3. Previous studies have linked LSD1 to malignancy in several human tumors, and LSD1 is considered to epigenetically regulate the energy metabolism genes in adipocytes and hepatocellular carcinoma. This stu...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.29714

    authors： Kosumi K,Baba Y,Sakamoto A,Ishimoto T,Harada K,Nakamura K,Kurashige J,Hiyoshi Y,Iwatsuki M,Iwagami S,Sakamoto Y,Miyamoto Y,Yoshida N,Oki E,Watanabe M,Hino S,Nakao M,Baba H

    更新日期：2016-01-15 00:00:00

  • Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas.

    abstract：:The karyotypes of cells from 10 Burkitt lymphoma (BL) biopsies, eight cell lines established from BL and nine cell lines from non-BL sources were studied by chromosome banding techniques. With the exception of the BL-derived cell lines BJAB, GC-BJAB, Maku and U-8691 all biopsies and lines of Burkitt origin contained a...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.2910170108

    authors： Zech L,Haglund U,Nilsson K,Klein G

    更新日期：1976-01-15 00:00:00

  • Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance.

    abstract：:Previous studies have shown that the in vitro-selected adriamycin-resistant human small-cell lung-carcinoma cell line GLC4-ADR150 displays multidrug resistance as the result of 3-fold decreased DNA-topoisomerase II (topo II) activity and a 6-fold reduction in adriamycin accumulation. Not the MDR1 gene, but the MRP gen...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.2910610317

    authors： Versantvoort CH,Withoff S,Broxterman HJ,Kuiper CM,Scheper RJ,Mulder NH,de Vries EG

    更新日期：1995-05-04 00:00:00

  • Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle-invasive bladder cancer.

    abstract：:The aim of this study was to test the utility of AIMP3, an upstream regulator of DNA damage response following genotoxic stress, as a clinical biomarker in muscle-invasive bladder cancer (MIBC). AIMP3 was identified from a meta-analysis of a global gene-expression dataset. AIMP3 protein expression was determined by im...

    journal_title：International journal of cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1002/ijc.29022

    authors： Gurung PM,Veerakumarasivam A,Williamson M,Counsell N,Douglas J,Tan WS,Feber A,Crabb SJ,Short SC,Freeman A,Powles T,Hoskin PJ,West CM,Kelly JD

    更新日期：2015-02-01 00:00:00

  • A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma.

    abstract：:Previous studies have reported an association between hot tea drinking and risk of esophageal cancer, but no study has examined this association using prospectively and objectively measured tea drinking temperature. We examined the association of tea drinking temperature, measured both objectively and subjectively at ...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.32220

    authors： Islami F,Poustchi H,Pourshams A,Khoshnia M,Gharavi A,Kamangar F,Dawsey SM,Abnet CC,Brennan P,Sheikh M,Sotoudeh M,Nikmanesh A,Merat S,Etemadi A,Nasseri Moghaddam S,Pharoah PD,Ponder BA,Day NE,Jemal A,Boffetta P,Mal

    更新日期：2020-01-01 00:00:00

  • Mutant allele-specific imbalance modulates prognostic impact of KRAS mutations in colorectal adenocarcinoma and is associated with worse overall survival.

    abstract：:The prognostic impact of distinct KRAS mutations in colorectal carcinomas is not fully characterized. We hypothesized that the prognostic impact of KRAS mutations is modulated by KRAS mutant allele-specific imbalance (MASI). KRAS MASI was assessed by sequencing electropherograms in KRAS-mutated colorectal carcinomas (...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.27461

    authors： Hartman DJ,Davison JM,Foxwell TJ,Nikiforova MN,Chiosea SI

    更新日期：2012-10-15 00:00:00

  • Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with solid cancers: The CSR FENCE score.

    abstract：:The absolute risk reduction by prophylaxis in chemotherapy-induced febrile neutropenia (FN) is largest in patients at highest underlying risk. Therefore, reliable predictive models are needed. Here, we develop and validate such a model for risk of FN during chemotherapy cycles 2-6. A prediction score for risk of FN du...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.32249

    authors： Aagaard T,Reekie J,Roen A,Daugaard G,Specht L,Sengeløv H,Mocroft A,Lundgren J,Helleberg M

    更新日期：2020-01-15 00:00:00

  • Tumoricidal activity and cytokine secretion by tumor-infiltrating macrophages.

    abstract：:Murine macrophages from different anatomical sites were compared for their ability to become tumoricidal and to secrete interleukin-1 (IL-1) and tumor necrosis factor (TNF) following stimulation in vitro by several biological response modifiers (BRM). Peritoneal macrophages (PM), alveolar macrophages (AM), and tumor-i...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.2910480513

    authors： Brunda MJ,Sulich V,Wright RB,Palleroni AV

    更新日期：1991-07-09 00:00:00

  • CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer.

    abstract：:To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mixed lymphocyte tumor...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/(sici)1097-0215(19981209)78:6<685::aid-ijc

    authors： Bixby DL,Yannelli JR

    更新日期：1998-12-09 00:00:00

  • The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma.

    abstract：:Mantle cell lymphoma (MCL) is an aggressive and incurable malignant disease. Despite of general chemotherapy, relapse and mortality are common, highlighting the need for the development of novel targeted drugs or combination of therapeutic regimens. Recently, several drugs that target the B-cell receptor (BCR) signali...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.31044

    authors： Li J,Wang X,Xie Y,Ying Z,Liu W,Ping L,Zhang C,Pan Z,Ding N,Song Y,Zhu J

    更新日期：2018-01-01 00:00:00

  • High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.

    abstract：:Interest has increased in the potential role of circulating tumour cells in cancer management. Most cell-based studies have been designed to determine the number of circulating tumour cells in a given volume of blood. Ability to understand the biology of the cancer cells would increase the clinical potential. The purp...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.29680

    authors： Dent BM,Ogle LF,O'Donnell RL,Hayes N,Malik U,Curtin NJ,Boddy AV,Plummer ER,Edmondson RJ,Reeves HL,May FE,Jamieson D

    更新日期：2016-01-01 00:00:00

  • Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study.

    abstract：:Noninvasive biomarkers for early pancreatic ductal adenocarcinoma (PDAC) diagnosis and disease risk stratification are greatly needed. We conducted a nested case-control study within the Prospective Investigation into Cancer and Nutrition (EPIC) cohort to evaluate prediagnostic microRNAs (miRs) as biomarkers of subseq...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.30790

    authors： Duell EJ,Lujan-Barroso L,Sala N,Deitz McElyea S,Overvad K,Tjonneland A,Olsen A,Weiderpass E,Busund LT,Moi L,Muller D,Vineis P,Aune D,Matullo G,Naccarati A,Panico S,Tagliabue G,Tumino R,Palli D,Kaaks R,Katzke VA,

    更新日期：2017-09-01 00:00:00

  • Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3.

    abstract：:Signal transducer and activator of transcription 3 (STAT3) is activated in a variety of human cancers, including ovarian cancer. The molecular mechanism by which the STAT3 is activated in cancer cells is poorly understood. We observed that human ovarian xenograft tumors (A2780) in mice were severely hypoxic (pO(2) app...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.24601

    authors： Selvendiran K,Bratasz A,Kuppusamy ML,Tazi MF,Rivera BK,Kuppusamy P

    更新日期：2009-11-01 00:00:00

  • Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer.

    abstract：:Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with high proliferative and metastatic phenotypes. CDCA7, a new member of the cell division cycle associated family of genes, is involved in embryonic development and dysregulated in various types of human cancer. However, the biologi...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.31766

    authors： Ye L,Li F,Song Y,Yu D,Xiong Z,Li Y,Shi T,Yuan Z,Lin C,Wu X,Ren L,Li X,Song L

    更新日期：2018-11-15 00:00:00

  • Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.

    abstract：:This review is one of two complementary reviews that have been prepared in the framework of the Eurogin Roadmap 2015 to evaluate how knowledge about HPV is changing practices in HPV infection and disease control through vaccination and screening. In this review of HPV vaccine knowledge, we present the most significant...

    journal_title：International journal of cancer

    pub_type： 杂志文章,评审

    doi：10.1002/ijc.30063

    authors： Brotherton JM,Jit M,Gravitt PE,Brisson M,Kreimer AR,Pai SI,Fakhry C,Monsonego J,Franceschi S

    更新日期：2016-08-01 00:00:00

  • Colorectal cancer chemoprevention by 2 beta-cyclodextrin inclusion compounds of auraptene and 4'-geranyloxyferulic acid.

    abstract：:The inhibitory effects of novel prodrugs, inclusion complexes of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid (GOFA) and auraptene (AUR) with beta-cyclodextrin (CD), on colon carcinogenesis were investigated using an azoxymethane (AOM)/dextran sodium sulfate (DSS) model. Male CD-1 (ICR) mice initiated wit...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.24833

    authors： Tanaka T,de Azevedo MB,Durán N,Alderete JB,Epifano F,Genovese S,Tanaka M,Tanaka T,Curini M

    更新日期：2010-02-15 00:00:00

  • Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.

    abstract：:Fibroblast growth factor 15 (FGF15), FGF19 in humans, is a gut-derived hormone and a key regulator of bile acids and carbohydrate metabolism. FGF15 also participates in liver regeneration after partial hepatectomy inducing hepatocellular proliferation. FGF19 is overexpressed in a significant proportion of human hepato...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.29287

    authors： Uriarte I,Latasa MU,Carotti S,Fernandez-Barrena MG,Garcia-Irigoyen O,Elizalde M,Urtasun R,Vespasiani-Gentilucci U,Morini S,de Mingo A,Mari M,Corrales FJ,Prieto J,Berasain C,Avila MA

    更新日期：2015-05-15 00:00:00

  • Multiple primary cancers as a guide to heritability.

    abstract：:There are approximately 100 genes which when mutated are known to predispose to one or more forms of cancer. Currently, genetic testing is offered for many of these, either as single genes or as multi-gene panels. Features of hereditary cancer include a positive family history of cancer, early age of onset and the app...

    journal_title：International journal of cancer

    pub_type： 杂志文章,评审

    doi：10.1002/ijc.28988

    authors： Cybulski C,Nazarali S,Narod SA

    更新日期：2014-10-15 00:00:00

  • Monoclonal antibody against a naturally occurring rat mammary carcinoma.

    abstract：:Inbred rats were hyper-immunised against a syngeneic transplanted mammary carcinoma, Sp4, which originally arose spontaneously in a breeding female. Spleen cells from Sp4-immune rats were fused with P3-NSI-Ag4 mouse myeloma cells, and supernatants from the hybrid progeny were screened for antibody reacting with Sp4 ce...

    journal_title：International journal of cancer

    pub_type： 杂志文章

    doi：10.1002/ijc.2910260311

    authors： Gunn B,Embleton MJ,Middle JG,Baldwin RW

    更新日期：1980-09-15 00:00:00